Wellell Biotech Announces 2025 Q4 Earnings: EPS of NT$2.96
Key facts
- Wellell Biotech Announces 2025 Q4 Earnings: EPS of NT$2.96
- Wellell Biotech Co., Ltd. (stock code 1783) reported its financial results for the fourth quarter of 2025. The company posted an earnings per share (EPS) of NT$2.96 for the quarter. Revenue reached NT$812 million, with a net profit after tax of NT$265 million. Wellell Biotech operates in the biotechnology and medical industry, focusing on collagen and hyaluronic acid.
- Source: PR Times
- Date: December 1, 2025
Direct answer
Wellell Biotech Co., Ltd. (stock code 1783) reported its financial results for the fourth quarter of 2025. The company posted an earnings per share (EPS) of NT$2.96 for the quarter. Revenue reached NT$812 million, with a net profit after tax of NT$265 million. Wellell Biotech operates in the biotechnology and medical industry, focusing on collagen and hyaluronic acid.
- Citation
- Wellell Biotech Announces 2025 Q4 Earnings: EPS of NT$2.96 (December 1, 2025), PR Times
- Source
- PR Times
- Date
- December 1, 2025
Wellell Biotech Co., Ltd. (stock code 1783) reported its financial results for the fourth quarter of 2025. The company posted an earnings per share (EPS) of NT$2.96 for the quarter. Revenue reached NT$812 million, with a net profit after tax of NT$265 million. Wellell Biotech operates in the biotechnology and medical industry, focusing on collagen and hyaluronic acid.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:20 (16h 20m after Collected)
Company Code: 1783
Company Name: Wellell Biotech Co., Ltd.
Industry: Biotechnology and Medical
Year/Quarter: 2025 Q4
Basic Earnings Per Share: NT$2.96
Operating Revenue: NT$812 million
Net Profit After Tax: NT$265 million
Company Name: Wellell Biotech Co., Ltd.
Industry: Biotechnology and Medical
Year/Quarter: 2025 Q4
Basic Earnings Per Share: NT$2.96
Operating Revenue: NT$812 million
Net Profit After Tax: NT$265 million
FAQ
What was Wellell Biotech's revenue in Q4 2025?
Wellell Biotech's operating revenue for Q4 2025 was NT$812 million.
What was Wellell Biotech's net profit in Q4 2025?
The net profit after tax for Wellell Biotech in Q4 2025 was NT$265 million.
What is Wellell Biotech's stock code?
Wellell Biotech's stock code is 1783.